Browsing Tag
Tandem Diabetes Care
6 posts
Is MiniMed (Nasdaq: MMED) worth watching after its IPO slide and before June earnings?
MiniMed (Nasdaq: MMED) is down from its IPO price. Read what June earnings, new product launches, and analyst targets could mean next.
Tandem Diabetes Care wins FDA clearance to bring its Tandem Mobi insulin pump app to Android users
Find out how Tandem Diabetes Care’s FDA clearance for its Android app expands insulin pump access and reshapes the diabetes tech market.
Why Tandem Diabetes Care’s shift to pharmacy access could fuel its $1bn 2025 target
Tandem Diabetes Care outlines its path to $1 billion in 2025 revenue driven by pharmacy channel expansion, higher recurring revenue and gross margin improvement.
Tandem Diabetes Care expands insulin pump integration with Abbott’s FreeStyle Libre 3 Plus sensor for U.S. diabetes patients
Tandem Diabetes Care integrates t:slim X2 insulin pump with Abbott’s FreeStyle Libre 3 Plus in the U.S., advancing automated insulin delivery personalization.
Game-changer for diabetes? Tandem’s Control-IQ+ automated insulin delivery system now available in the US
Tandem Diabetes Care launches Control-IQ+ automated insulin delivery for type 1 and type 2 diabetes, expanding access to advanced insulin automation in the U.S.
Insulin patch pump developer AMF Medical to be acquired by Tandem Diabetes Care
Tandem Diabetes Care, an American diabetes technology company, has agreed to acquire Switzerland-based insulin patch pump developer AMF…